The Cabinet yesterday approved a plan by the Government Pharmaceutical Organisation (GPO) to construct the second phase of its pharmaceutical plant in Rangsit area at a cost of Bt5.607 billion.
The move will help GPO to expand its production capacity to cope with the requirements of the Good Manufacturing Practice (GMP) standard.
Nattaporn Jatusripitak, an adviser in the Prime Minister's Office, said that the second phase of the plant would be financed over four years from 2018, from GPO’s income of Bt2.243 billion and local borrowings of Bt3.364 billion.
Of the total budget for the second phase, some Bt3.626 billion will be for the building and manufacturing facilities, Bt1.917 billion for machinery and equipment, and Bt63 million for project management and construction control.
The GPO has two pharmaceutical manufacturing facilities: a plant on Rama VI and the first phase of the Rangsit plant.